Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...

Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines. Through its partnerships, the Genetic Medicines division is ...

Illustration from a crystal structure of the coagulation factor thrombin inhibited by two drug–peptide nucleic acid (PNA) molecules (pink and purple) bound together by base pairing; a PNA antidote ...

Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...

Sourced from the rugged coastline of Brittany, France, the Eryngium maritimum - known as the "King of Stress Resistance" - ...

Codexis, Inc. , a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Group, an oligonucleotide Contract Research Development and ...

Please provide your email address to receive an email when new articles are posted on . Evidence of systemic mast cell activation in the PROSPECTOR study was split into three categories. A REMA score ...

Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...

Innodal is pleased to announce that the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) has issued a No Objection Letter (NOL) confirming the acceptability of INNEOtm ...

Can a nasal spray give you tanner skin, better digestion, and a pep in your step? Medical professionals sniff out the truth ...

The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.